Covid-19 man­u­fac­tur­ing roundup: Rus­sia will pro­duce Sput­nik V in Pe­ru — re­port; CEPI calls for es­tab­lished vac­cine use in tri­als

Pe­ru will in­stall a man­u­fac­tur­ing plant in-coun­try to pro­duce the Sput­nik V Covid-19 vac­cine out of Rus­sia, its Pres­i­dent Pe­dro Castil­lo an­nounced Mon­day.

Just about 25% of the pop­u­la­tion is ful­ly vac­ci­nat­ed, while 33% has re­ceived at least one jab. Since Au­gust, the dai­ly in­fec­tion rate has hov­ered around the 1,000 mark.

Rus­sia and Pe­ru inked a deal for 20 mil­lion dos­es of Sput­nik V in Ju­ly.

Brazil just backed out of an agree­ment for the vac­cine, cit­ing a lapsed reg­is­tra­tion dead­line, de­spite bat­tling one of the tough­est out­breaks in the world. Sput­nik V is still await­ing emer­gency use au­tho­riza­tion from the World Health Or­ga­ni­za­tion. In June, the agency took is­sue with its vial-fill­ing pro­ce­dures at a plant. A re­port iden­ti­fied prob­lems sur­round­ing the risk of cross-con­t­a­m­i­na­tion and said that track­ing and iden­ti­fy­ing batch­es of the vac­cine was a con­cern.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER